1. Home
  2. BMRA

BMRA

Biomerica Inc.

Logo Biomerica Inc.

Health Care

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Nasdaq

as 04-19-2024 3:34pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

Founded: 1971 Country:
United States
United States
Employees: N/A City: IRVINE
Market Cap: 14.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 57.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.37 EPS Growth: N/A
52 Week Low/High: $0.70 - $2.13 Next Earning Date: 04-12-2024
Revenue: $5,405,208 Revenue Growth: -43.29%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: